The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a randomized phase II/III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus docetaxel for high-grade soft tissue sarcomas: Japan Clinical Oncology Group study JCOG1306.
 
Kazuhiro Tanaka
Honoraria - Bayer Yakuhin; Daiichi Sankyo; Eisai; Hisamitsu Pharmaceutical; Taiho Pharmaceutical
 
Ryunosuke Machida
No Relationships to Disclose
 
Makoto Endo
Honoraria - Bayer
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - Bayer; Boehringer Ingelheim; Daiichi Sankyo; Eisai; Kyowa Kirin; Taiho Pharmaceutical; Teijin Ltd
Research Funding - AYUMI (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Taiho Pharmaceutical (Inst)
 
Akira Kawai
Honoraria - Boehringer Ingelheim; Taiho Pharmaceutical
 
Robert Nakayama
No Relationships to Disclose
 
Satoshi Tsukushi
No Relationships to Disclose
 
Kunihiro Asanuma
No Relationships to Disclose
 
Hiroaki Hiraga
No Relationships to Disclose
 
Koji Hiraoka
Honoraria - Asahi Kasei; Daiichi Sankyo; Hisamitsu Pharmaceutical
 
Shinichiro Yoshida
No Relationships to Disclose
 
Tsukasa Yonemoto
No Relationships to Disclose
 
Jungo Imanishi
No Relationships to Disclose
 
Hirohisa Katagiri
No Relationships to Disclose
 
Yoshihiro Nishida
Honoraria - Alexion Pharmaceuticals; Asahi Kasei; Astellas Pharma; Chugai Pharma; Daiichi Sankyo; Eisai; Hisamitsu Pharmaceutical; Kaken Pharmaceutical; Kyowa Hakko Kirin Co., Ltd.; Lilly Japan; Ono Pharmaceutical
Consulting or Advisory Role - Alexion Pharmaceuticals; Boehringer Ingelheim; Daiichi Sankyo; Seikagaku
Research Funding - Kuraray; Novartis (Inst); Zimmer BioMet (Inst)
 
Akihito Nagano
No Relationships to Disclose
 
Yuta Sekino
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; CMIC Co., Ltd.; Kyowa Kirin Co., Ltd.; m3.com
 
Toshifumi Ozaki
No Relationships to Disclose
 
Yukihide Iwamoto
No Relationships to Disclose